The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast

ConclusionsAIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative ILC.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research